Aelis Farma S.A.
AELIS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €3 | €9 | €4 | €9 |
| % Growth | -70.4% | 137.7% | -58% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €3 | €9 | €4 | €9 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | €10 | €16 | €14 | €7 |
| G&A Expenses | €3 | €1 | €2 | €1 |
| SG&A Expenses | €3 | €1 | €2 | €1 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €2 | -€3 | -€1 |
| Operating Expenses | €13 | €19 | €12 | €7 |
| Operating Income | -€8 | -€6 | -€9 | €3 |
| % Margin | -288.8% | -71.4% | -223.8% | 28.1% |
| Other Income/Exp. Net | €0 | €1 | -€6 | -€1 |
| Pre-Tax Income | -€7 | -€5 | -€14 | €2 |
| Tax Expense | €0 | €0 | €0 | €1 |
| Net Income | -€7 | -€5 | -€14 | €1 |
| % Margin | -278.4% | -56.1% | -375.1% | 6.3% |
| EPS | -0.54 | -0.39 | -1.21 | 0.06 |
| % Growth | -38.5% | 67.8% | -2,123.4% | – |
| EPS Diluted | -0.54 | -0.39 | -1.21 | 0.06 |
| Weighted Avg Shares Out | 14 | 13 | 12 | 10 |
| Weighted Avg Shares Out Dil | 14 | 13 | 12 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | -€1 | €0 | €0 | €0 |
| EBITDA | -€9 | -€6 | -€16 | €1 |
| % Margin | -321.8% | -70.1% | -426% | 9.3% |